28th Mar 2025 15:03
28 March 2025
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 27 March 2025 that a person closely associated with Richard Gray, Non-executive Director of the Company, performed a 'Bed and ISA' transfer of 305 ordinary shares of 0.2p each in the Company ("Ordinary Shares") from their share dealing account to their ISA account on 26 March 2025.
As a result, Richard Gray's total interest in the Company, including all persons closely associated, remains at 7,600 Ordinary Shares, representing 0.011% per cent of the total voting rights of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||||||||
a)
| Name
| Jennifer Gray | |||||||||
2
| Reason for the notification
| ||||||||||
a)
| Position/status
| PCA | |||||||||
b)
| Initial notification /Amendment
| Initial Notification | |||||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||||||||
a)
| Name
| CVS Group plc | |||||||||
b)
| LEI
| 213800J41XDQ2NX48O05 | |||||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||||||||
a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 0.2 pence each
GB00B2863827
| |||||||||
b)
| Nature of the transaction
| On-market purchase | |||||||||
c)
| Price(s) and volume(s)
|
| |||||||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Aggregated volume = 305
Aggregated sale price = £3,071.92
Aggregated purchase price = £3,077.40 | |||||||||
e)
| Date of the transaction
| 26 March 2025 | |||||||||
f)
| Place of the transaction
| London Stock Exchange - AIM (XLON) | |||||||||
Related Shares:
CVS Group